Areas of Growth in the Management of EGFR-Mutated Lung Cancer
Liza C. Villaruz, MD, discusses what research in the EGFR-positive lung cancer space has recently caught the attention of experts.
Villaruz on the Benefit of Adagrasib in KRAS G12C-Mutated NSCLC
Liza C. Villaruz, MD, discusses what research in the KRAS G12C-mutated non–small cell lung cancer space has appeared to be most promising in recent years.
Top Targets and Novel Biomarkers Attract Interest in NSCLC
Liza C. Villaruz, MD, discusses the most promising biomarkers in the non–small cell lung cancer space.
Villaruz Discusses Updates in Biomarker-Driven Lung Cancer
Liza C. Villaruz, MD, discusses the latest areas of growth in the non–small cell lung cancer space.